Q2 2020 Holdings
Filed 2020-08-04 | 26 holdings | $336.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $318.8M | 10,542,790 | 94.8% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $16.5M | 943,666 | 4.9% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $191.8K | 5,827,415 | 0.1% |
| Passage BIO Inc | COM | 702712100 | $136.9K | 5,009,219 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $73.0K | 2,309,554 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $69.4K | 3,566,912 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $51.7K | 2,316,447 | 0.0% |
| Translate BIO Inc | COM | 89374L104 | $39.1K | 2,182,789 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $37.1K | 895,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $36.0K | 1,312,999 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $30.0K | 1,437,028 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $25.0K | 2,571,450 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $22.3K | 2,755,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $19.6K | 1,320,045 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $13.7K | 2,061,758 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $13.3K | 3,190,079 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $12.1K | 2,364,500 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $11.1K | 528,000 | 0.0% |
| Allena Pharmaceuticals Inc(ALNAEUR) | COM | 018119107 | $5.3K | 3,330,373 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $4.8K | 1,312,258 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $2.9K | 4,256,526 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.5K | 202,803 | 0.0% |
| VTV Therapeutics Inc | CL A | 918385105 | $2.4K | 1,062,000 | 0.0% |
| Iterum Therapeutics PLC | SHS | G6333L101 | $1.8K | 1,538,316 | 0.0% |
| Entasis Therapeutics Hldgs I | COM | 293614103 | $1.0K | 349,953 | 0.0% |
| Bellicum Pharmaceuticals Inc(BLCMEUR) | COM NEW | 079481404 | $781 | 105,144 | 0.0% |